Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -64.08 Million | 1.58 Billion | 259.61 Million | 282.15 Million | 68.34 Million | 29.7 Million |
| Net Income | 355.01 Million | 1.02 Billion | 203.84 Million | 207.95 Million | 106.07 Million | 38.03 Million |
| Depreciation & Amortization | 210.25 Million | 144.6 Million | 99.31 Million | 69.5 Million | 50.39 Million | 26.1 Million |
| Deferred income taxes | -3.92 Million | -17.52 Million | -3.25 Million | 5.6 Million | - | - |
| Stock-based compensation | 13.4 Million | 21.4 Million | - | - | - | - |
| Change in working capital | -566.02 Million | 294.95 Million | -81.8 Million | -28.09 Million | -120.81 Million | -48.45 Million |
| Other non-cash items | 927.13 Million | 118.19 Million | 38.25 Million | 32.78 Million | 32.68 Million | 14.02 Million |
| Investing Cash Flow | -603.59 Million | -869.83 Million | -461.08 Million | -167.75 Million | -146.54 Million | -184.32 Million |
| Investments in PPE | -662.71 Million | -565.37 Million | -372.66 Million | -189.39 Million | -128.09 Million | -186.39 Million |
| Acquisitions | 18.86 Million | -6.3 Million | 4.68 Million | 209 Thousand | 50.09 Thousand | 385.07 Thousand |
| Investment purchases | -240.22 Million | -774.47 Million | -636.68 Million | -209 Thousand | -90.05 Million | -31.1 Million |
| Sales/Maturities of investments | 262.46 Million | 498.01 Million | 548.26 Million | 20.18 Million | 70.45 Million | 31.4 Million |
| Other Investing Activities | 18 Million | -21.68 Million | -4.68 Million | 1.44 Million | 1.09 Million | 1.37 Million |
| Financing Cash Flow | -59.63 Million | 13.47 Million | 447.54 Million | -8.76 Million | 142.43 Million | 133.55 Million |
| Debt repayment | -252.08 Million | -443.47 Million | -86.16 Million | -622.09 Million | -144.95 Million | -44.45 Million |
| Dividends payments | -255.65 Million | -162 Million | -10.9 Million | -21.84 Million | -1 Million | -10.45 Million |
| Common Stock Repurchased | - | - | - | 4.75 Million | - | - |
| Common Stock Issuance | - | - | -18.48 Million | -4.75 Million | - | - |
| Other Financing Activities | -56.06 Million | 625.94 Million | 544.61 Million | 649.56 Million | 310.22 Million | 188.46 Million |
| Accounts receivables | 12.93 Million | -190.33 Million | -54.95 Million | -58.24 Million | -34.86 Million | -23.72 Million |
| Accounts payables | -477.24 Million | 843.33 Million | 43.77 Million | 45.42 Million | 34.86 Million | - |
| Inventory | -101.71 Million | -340.51 Million | -67.36 Million | -20.87 Million | -54.22 Million | -44.43 Million |
| Other working capital | 13.48 Million | -17.52 Million | -3.25 Million | 5.6 Million | -66.59 Million | -4.01 Million |
| Cash at beginning of period | 1.25 Billion | 473.85 Million | 229.18 Million | 126.15 Million | 61.91 Million | 82.92 Million |
| Cash at end of period | 490.58 Million | 1.21 Billion | 473.85 Million | 229.18 Million | 126.15 Million | 61.91 Million |
| Capital Expenditure | -662.71 Million | -565.37 Million | -372.66 Million | -189.39 Million | -128.09 Million | -186.39 Million |
| Effect of forex changes on cash | 3.98 Million | 10.25 Million | -1.4 Million | -2.6 Million | 1735.68 | 51.39 Thousand |
| Net cash flow / Change in cash | -759.96 Million | 737.05 Million | 244.67 Million | 103.03 Million | 64.23 Million | -21.01 Million |
| Free Cash Flow | -726.8 Million | 1.01 Billion | -113.04 Million | 92.76 Million | -59.75 Million | -156.68 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 45.6 Million | 106.99 Million | 66.03 Million | 69.99 Million | 355.01 Million | 143.48 Million |
| Depreciation & Amortization | - | 59.85 Million | 59.85 Million | 56.84 Million | 210.25 Million | -89.05 Million |
| Deferred income taxes | - | - | - | - | -3.92 Million | 9.53 Million |
| Stock-based compensation | - | 9.62 Million | - | 13.4 Million | 13.4 Million | -7.01 Million |
| Change in working capital | - | -38.47 Million | - | -75.29 Million | -566.02 Million | 84.67 Million |
| Other non-cash items | 131.83 Million | 26.59 Million | 5.75 Million | 370.43 Million | 927.13 Million | -85.99 Million |
| Investing Cash Flow | -299.85 Million | -136.81 Million | -93.43 Million | -228.54 Million | -603.59 Million | -174.11 Million |
| Investments in PPE | -164.17 Million | -151.22 Million | -134.01 Million | -219.07 Million | -662.71 Million | -145.07 Million |
| Acquisitions | - | - | -42.36 Million | -21.56 Million | 18.86 Million | 50.83 Thousand |
| Investment purchases | -152.5 Million | -109.39 Million | -20.2 Million | -18.66 Million | -240.22 Million | -30.01 Million |
| Sales/Maturities of investments | 18.65 Million | 123.81 Million | 60.78 Million | -165.54 Thousand | 262.46 Million | 31.85 Million |
| Other Investing Activities | -1.83 Million | 17.52 Million | 42.36 Million | 30.93 Million | 18 Million | -30.93 Million |
| Financing Cash Flow | -67.12 Million | 150.35 Million | 35.73 Million | -177.88 Million | -59.63 Million | 84.94 Million |
| Debt repayment | -99.98 Million | -149.01 Million | -36.6 Million | -114.66 Million | -252.08 Million | -18 Million |
| Dividends payments | -161.58 Million | -1.67 Million | -1.09 Million | -255.65 Million | -255.65 Million | -1.16 Million |
| Common Stock Repurchased | - | - | - | - | - | 12.57 Million |
| Common Stock Issuance | - | - | - | - | - | -12.57 Million |
| Other Financing Activities | -5.52 Million | 4.08 Million | -872.63 Thousand | 192.43 Million | -56.06 Million | 104.11 Million |
| Accounts receivables | - | -42.34 Million | - | 12.93 Million | 12.93 Million | -24.32 Million |
| Accounts payables | - | - | - | - | -477.24 Million | 7.01 Million |
| Inventory | - | -6.97 Million | - | -101.71 Million | -101.71 Million | 108.99 Million |
| Other working capital | - | 10.85 Million | - | 13.48 Million | 13.48 Million | -7.01 Million |
| Cash at beginning of period | 586.24 Million | 495.88 Million | 490.58 Million | 480.22 Million | 1.25 Billion | 508.03 Million |
| Cash at end of period | 396.96 Million | 595.46 Million | 495.88 Million | 490.58 Million | 490.58 Million | 472.94 Million |
| Capital Expenditure | -164.17 Million | -151.22 Million | -134.01 Million | -219.07 Million | -662.71 Million | -145.07 Million |
| Effect of forex changes on cash | 424.63 Thousand | -928.41 Thousand | -1.77 Million | -943.54 Thousand | 3.98 Million | -1.54 Million |
| Net cash flow / Change in cash | -189.27 Million | 99.57 Million | 5.3 Million | 10.36 Million | -759.96 Million | -35.08 Million |
| Free Cash Flow | 13.26 Million | -77.48 Million | -62.22 Million | 202.9 Million | -726.8 Million | -89.44 Million |
CECO
5Y7
000755
Q
CHRW
FMC